He has had an interim Top Secret clearance for months, and now it has been reduced to a secret clearance, because, between his lies misstatements on his clearance forms and his extensive debts to a veritable rogues gallery he is a walking security risk.
We’ve already had reports of multiple foreign governments using his precarious financial situation and closeness to Donald Trump to attempt to derive leverage with the White House, so this was a logical decision to make.
Matt Bruenig details the professional history of Chelsea Clinton, and it is a miasma and nepotism.
If she runs for office, and it is clear that Hillary, at least, wants her to continue in the “family business”, her entry in politics would be a disaster:
Rumors are that Chelsea Clinton is gearing up to run for office. This is troubling news insofar as it might keep the Clinton machine and its hangers-on in politics. It also seems like a questionable idea insofar as Clinton is a nepotist legacy case whose whole career to this point has been hopping from one dodgy patronage job to another, not exactly the ideal image for the Democratic Party.
McKinsey (2003–2006)
After graduating high school, Chelsea goes to Stanford and gets a degree in history and then goes to Oxford and gets a degree in international relations. So far, so banal.
But after Oxford, Chelsea Clinton signed up with McKinsey, a consulting company known as an elite business training corps. She was the youngest in her class, hired at the same rank as those with M.B.A. degrees. Her interview was more like a conversation, said D. Ronald Daniel, a senior partner. “That’s why she was a good consultant, because we are professional question-askers and professional listeners,” Mr. Daniel said. — New York Times
Despite having no background in business, statistics, or any other related field, Chelsea gets hired by McKinsey straight out of Oxford alongside elite business school graduates. The interview process for that was “more like a conversation.”
It goes on from there, and it’s an exercise in corrosive nepotism, including a gig with NBC that boils down to “$26,724 for each minute she subsequently appeared on air” and I agree with Breunig’s final conclusion:
You could not put together a more unappealing force in the world than what Chelsea Clinton represents, personally or politically.
It doesn’t make her a bad person, but it makes any entry into electoral politics by her an unmitigated catastrophe.
It looks like the Clintons are 
now grooming Chelsea for a potential run for Congress:
While some pundits are declaring the Clinton political dynasty dead, sources tell us that it is far from over. Chelsea Clinton is being groomed for the New York seat held by Rep. Nita Lowey.
Chelsea could run for the seat in NYC’s 17th Congressional District once Lowey, a respected, 79-year-old career politician with nearly 30 years in office, decides to retire, we have exclusively learned.
Lowey’s district includes parts of Rockland and Westchester counties and, conveniently, Chappaqua, the Clinton family home base.
The only thing that I can think to add is a Sam Kinnison quote:
YOU DON’T HAVE TO LEAVE YET, DO YOU?!….YOU HAVEN’T SHOVED A CHAINSAW UP MY ASS YET!….MY HEAD’S STILL ON MY TORSO!!….I’M GLAD YOU F%$#ERS CAN HANDLE YOUR HIGH!
Seriously, too soon. Way too soon.
Hell………This century is too soon.
*H/t Lambert Strether for the title.
After Gayle Manchin took over the National Association of State Boards of Education in 2012, she spearheaded an unprecedented effort that encouraged states to require schools to purchase medical devices that fight life-threatening allergic reactions.
The association’s move helped pave the way for Mylan Specialty, maker of EpiPens, to develop a near monopoly in school nurses’ offices. Eleven states drafted laws requiring epinephrine auto-injectors. Nearly every other state recommended schools stock them after what the White House called the “EpiPen Law” in 2013 gave funding preference to those that did.
The CEO of Mylan then, and now, was Heather Bresch. Gayle Manchin is Heather Bresch’s mother.
The whole Manchin clan is in on this bit of looting.
On the bright side, both New York (first link) and West Virginia are looking at antitrust and Medicate fraud allegations against the firm:
On the eve of a Congressional hearing on the soaring price and lack of competition for the EpiPen emergency allergy treatment, the attorney general for West Virginia has confirmed his office is investigating EpiPen maker Mylan for allegations of antitrust violations and Medicaid fraud.
WV Attorney General Patrick Morrisey confirmed the investigation today, revealing that he’d issued a subpoena to Mylan back in August, seeking documents and other information related to EpiPen, but that the company failed to meet the Sept. 7 deadline.
In response, Morrisey’s office has petitioned [PDF] a state circuit court to enforce that subpoena.
The state believes that EpiPen has been short-changing the West Virginia Department of Health and Human Services Bureau for Medical Services (BMS) by paying smaller rebates than it should have.
Drug companies pay different levels of rebates to BMS depending on whether a medication is considered an “innovator” or a “non-innovator.” The lower, non-innovator distinction, is usually reserved for generics, but Morrisey says that Mylan was paying that rate for EpiPen, even though it’s a brand-name drug.
This may constitute Medicaid fraud under state law, according to the petition.
The state also believes that Mylan may have violated state antitrust laws by filing an intellectual property suit against Teva Pharmaceuticals in 2012 over an in-development generic version of EpiPen.
Joe Manchin will lose his bid for reelection in 2018.
If the Democratic base does not aggressively primary him, they are idiots.